August 2018 FDA Recall Lisinopril by Lupin Pharmaceuticals Inc.
D-1077-2018 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Lupin Pharmaceuticals Inc. on August 13, 2018 for the product Lisinopril. The FDA reported the reason for recall as presence of foreign substance. The product was distributed in Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States. and the recall is currently terminated.

Recall Number: D-1077-2018

Reason for Recall
Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
Initiated
08-13-2018
Reported
08-22-2018
Quantity
11,706 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Lupin Pharmaceuticals Inc.
Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States.
Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03

Batch or Lot Expiration Information

Lot# : H800414, Exp. 12/2019